|
|
||||||||
The Journal of Immunology, Vol 150, Issue 7 2901-2909, Copyright © 1993 by American Association of Immunologists
ARTICLES |
SH Gregory, EJ Wing, RA Hoffman and RL Simmons
Department of Medicine, University of Pittsburgh School of Medicine, PA 15213.
Reactive nitrogen intermediates (RNI), e.g., nitric oxide derived from a terminal guanido nitrogen atom of L-arginine, exhibit potent antimicrobial activity in vitro. The function of these intermediates in host defenses in vivo, however, is presently unclear. Experiments were undertaken to determine the role of RNI in the resolution of primary listerial infections of the liver. Serum RNI levels were elevated significantly in mice infected with Listeria monocytogenes. Moreover, a marked increase in RNI production was found in cultures of the parenchymal, as well as the nonparenchymal, liver cells obtained from Listeria-infected mice. RNI did not kill Listeria treated directly, however, nor were they a factor in the listericidal activity exhibited by hepatic cells. Rather, the elevated production of RNI during primary infection appeared to promote the replication of Listeria in vivo. Mice administered NG-monomethyl-L-arginine, a competitive inhibitor of RNI production, exhibited a 10- and a 100-fold reduction in the number of Listeria in their lives on days 3 and 7 postinfection, respectively. In vitro, NG-monomethyl-L-arginine stimulated the Ag-specific proliferation of T lymphocytes derived from Listeria-infected mice at concentrations that inhibited RNI production. These latter findings suggest that the elevated production of RNI during primary listerial infections suppresses host defenses by diminishing the proliferation and, consequently, the biologic response of immune cell populations.
This article has been cited by other articles:
![]() |
R. Appelberg Macrophage nutriprive antimicrobial mechanisms J. Leukoc. Biol., June 1, 2006; 79(6): 1117 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Mahidhara, R. A. Hoffman, S. Huang, A. Wolf-Johnston, Y. Vodovotz, R. L. Simmons, and T. R. Billiar Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation J. Leukoc. Biol., September 1, 2003; 74(3): 403 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Gregory and E. J. Wing Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections J. Leukoc. Biol., August 1, 2002; 72(2): 239 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Xu, J.-S. Yang, H. Link, and B.-G. Xiao SIN-1, a Nitric Oxide Donor, Ameliorates Experimental Allergic Encephalomyelitis in Lewis Rats in the Incipient Phase: The Importance of the Time Window J. Immunol., May 1, 2001; 166(9): 5810 - 5816. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Sprong, M. F. E. Hulstein, and R. van der Meer Quantifying Translocation of Listeria monocytogenes in Rats by Using Urinary Nitric Oxide-Derived Metabolites Appl. Envir. Microbiol., December 1, 2000; 66(12): 5301 - 5305. [Abstract] [Full Text] |
||||
![]() |
M. Medot-Pirenne, M. J. Heilman, M. Saxena, P. E. McDermott, and C. D. Mills Augmentation of an Antitumor CTL Response In Vivo by Inhibition of Suppressor Macrophage Nitric Oxide J. Immunol., December 1, 1999; 163(11): 5877 - 5882. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Allione, P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli Nitric Oxide Suppresses Human T Lymphocyte Proliferation Through IFN-{gamma}-Dependent and IFN-{gamma}-Independent Induction of Apoptosis J. Immunol., October 15, 1999; 163(8): 4182 - 4191. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Martins, L. Q. Vieira, F. Q. Cunha, and J. S. Silva Gamma Interferon Modulates CD95 (Fas) and CD95 Ligand (Fas-L) Expression and Nitric Oxide-Induced Apoptosis during the Acute Phase of Trypanosoma cruzi Infection: a Possible Role in Immune Response Control Infect. Immun., August 1, 1999; 67(8): 3864 - 3871. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. KRADIN, H.-W. LIU, N. van ROOIJEN, K. SPRINGER, L.-H. ZHAO, and C. P. LEARY Pulmonary Immunity to Listeria Is Enhanced by Elimination of Alveolar Macrophages Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1967 - 1974. [Abstract] [Full Text] |
||||
![]() |
M. S. Gomes, M. Florido, T. F. Pais, and R. Appelberg Improved Clearance of Mycobacterium avium Upon Disruption of the Inducible Nitric Oxide Synthase Gene J. Immunol., June 1, 1999; 162(11): 6734 - 6739. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S.-P. Tan, C. Feng, Y. Asano, and A. U. Kara Altered Immune Response of Interferon Regulatory Factor 1-Deficient Mice against Plasmodium berghei Blood-Stage Malaria Infection Infect. Immun., May 1, 1999; 67(5): 2277 - 2283. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan and M. Moretto Role of Gamma Interferon in Cellular Immune Response against Murine Encephalitozoon cuniculi Infection Infect. Immun., April 1, 1999; 67(4): 1887 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Schwacha, J. J. Meissler Jr., and T. K. Eisenstein Salmonella typhimurium Infection in Mice Induces Nitric Oxide-Mediated Immunosuppression through a Natural Killer Cell-Dependent Pathway Infect. Immun., December 1, 1998; 66(12): 5862 - 5866. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Koblish, C. A. Hunter, M. Wysocka, G. Trinchieri, and W. M.F. Lee Immune Suppression by Recombinant Interleukin (rIL)-12 Involves Interferon gamma Induction of Nitric Oxide Synthase 2 (iNOS) Activity: Inhibitors of NO Generation Reveal the Extent of rIL-12 Vaccine Adjuvant Effect J. Exp. Med., November 2, 1998; 188(9): 1603 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Wu-Hsieh, W. Chen, and H.-J. Lee Nitric Oxide Synthase Expression in Macrophages of Histoplasma capsulatum-Infected Mice Is Associated with Splenocyte Apoptosis and Unresponsiveness Infect. Immun., November 1, 1998; 66(11): 5520 - 5526. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Bocca, E. E. Hayashi, A. G. Pinheiro, A. B. Furlanetto, A. P. Campanelli, F. Q. Cunha, and F. Figueiredo Treatment of Paracoccidioides brasiliensis-Infected Mice with a Nitric Oxide Inhibitor Prevents the Failure of Cell-Mediated Immune Response J. Immunol., September 15, 1998; 161(6): 3056 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohya, Y. Tanabe, M. Makino, T. Nomura, H. Xiong, M. Arakawa, and M. Mitsuyama The Contributions of Reactive Oxygen Intermediates and Reactive Nitrogen Intermediates to Listericidal Mechanisms Differ in Macrophages Activated Pre- and Postinfection Infect. Immun., September 1, 1998; 66(9): 4043 - 4049. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. LIU, A. ANAND, K. BLOCH, D. CHRISTIANI, and R. KRADIN Expression of Inducible Nitric Oxide Synthase by Macrophages in Rat Lung Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 223 - 228. [Abstract] [Full Text] |
||||
![]() |
T. Fehr, G. Schoedon, B. Odermatt, T. Holtschke, M. Schneemann, M. F. Bachmann, T. W. Mak, I. Horak, and R. M. Zinkernagel Crucial Role of Interferon Consensus Sequence Binding Protein, but neither of Interferon Regulatory Factor 1 nor of Nitric Oxide Synthesis for Protection Against Murine Listeriosis J. Exp. Med., March 3, 1997; 185(5): 921 - 932. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |